LAMPERTICO, PIETRO

LAMPERTICO, PIETRO  

Dipartimento di Fisiopatologia Medico-Chirurgica e dei Trapianti  

Mostra records
Risultati 1 - 20 di 396 (tempo di esecuzione: 0.0 secondi).
Titolo Data di pubblicazione Autori Tipo File Abstract
Comparing methods for plasma HDV RNA quantification in bulevirtide-treated and untreated patients with HDV 2025 Anolli, Maria PaolaFacchetti, FlorianaLampertico, Pietro + Article (author) -
Comprehensive investigation of platelet function in patients with cirrhosis 2024 Ghali, ClaudiaLa Mura, VincenzoLampertico, PietroPeyvandi, FloraTripodi, Armando + Article (author) -
COVID-19 Vaccine in Lung and Liver Transplant Recipients Exceeds Expectations: An Italian Real-Life Experience on Immunogenicity and Clinical Efficacy of BNT162b2 Vaccine 2024 Morlacchi, Letizia CorinnaAlicandro, GianfrancoUceda Renteria, SaraZignani, NunzioCitterio, GaiaLombardi, AndreaRosso, LorenzoLampertico, PietroBlasi, Francesco + Article (author) -
A holistic evaluation of patients with chronic Hepatitis D virus (HDV) infection enrolled in the Italian PITER-B and delta cohort 2024 Pier Maria BattezzatiPaola BrambillaFederica CeriniPietro LamperticoAnna Licata + Article (author) -
Reappraisal of the conventional hemostasis tests as predictors of perioperative bleeding in the era of rebalanced hemostasis in cirrhosis 2024 La Mura, VincenzoLampertico, PietroPeyvandi, Flora + Article (author) -
Modelling HDV kinetics under the entry inhibitor bulevirtide suggests the existence of two HDV-infected cell populations 2024 Anolli, Maria PaolaUceda Renteria, Sara ColoniaLampertico, Pietro + Article (author) -
Induced myocardial ischemia in candidates to liver transplantation without evidence of heart disease 2023 Faggiano, AndreaLampertico, PietroVicenzi, MarcoRuscica, MassimilianoCarugo, Stefano + Article (author) -
Chronic Hepatitis B Finite Treatment: Similar and Different Concerns With New Drug Classes 2023 Pietro Lampertico + Article (author) -
No virologic resistance to bulevirtide monotherapy detected in patients through 24 weeks treatment in phase II and III clinical trials for chronic hepatitis delta 2023 Lampertico P + Article (author) -
Hepatitis D virus infection: Pathophysiology, epidemiology and treatment. Report from the first international delta cure meeting 2022 2023 Lampertico P. + Article (author) -
Spike-specific humoral and cellular immune responses after COVID-19 mRNA vaccination in patients with cirrhosis: A prospective single center study 2023 Matilde TopaAndrea LombardiRiccardo CacciaAlessandra BanderaAndrea GoriPietro Lampertico + Article (author) -
Carvedilol to reduce the risk of decompensation in patients with compensated cirrhosis: Is it really needed in patients with cured HCV or suppressed HBV? 2023 Pietro Lampertico + Article (author) -
Deregulated intracellular pathways define novel molecular targets for HBV-specific CD8 T cell reconstitution in chronic hepatitis B 2023 Lampertico P + Article (author) -
Reproducibility and accuracy of a pocket-size ultrasound device in assessing liver steatosis 2023 Andrea SorgeLuca ValentiMaurizio VecchiPietro Lampertico + Article (author) -
A Phase 3, Randomized Trial of Bulevirtide in Chronic Hepatitis D 2023 Lampertico P. + Article (author) -
Metabolic dysfunction outperforms ultrasonographic steatosis to stratify hepatocellular carcinoma risk in patients with advanced hepatitis C cured with direct‐acting antivirals 2023 Pietro LamperticoLuca Valenti + Article (author) -
Bulevirtide‐based treatment strategies for chronic hepatitis delta: A review 2023 Elisabetta DegasperiMaria Paola AnolliPietro Lampertico Article (author) -
Phenotypic CD8 T cell profiling in chronic hepatitis B to predict HBV-specific CD8 T cell susceptibility to functional restoration in vitro 2023 Penna ALoglio ASoffredini RAlfieri ALampertico P + Article (author) -
A 3-Year Course Of Bulevirtide Monotherapy May Cure Hdv Infection In Cirrhotics 2023 Maria Paola AnolliPietro Lampertico + Article (author) -
Profiling the risk of hepatocellular carcinoma after long-term HCV eradication in patients with liver cirrhosis in the PITER cohort 2023 Maria Grazia RumiPietro Lampertico + Article (author) -